81 results
Page 2 of 5
6-K
EX-10.1
rz9veort26 zei
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
i9vs yarj
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
ibda pet8v1p
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-99.1
8ywv olk75p0nx6vyj
17 Nov 20
Enlivex Appoints Former ArQule, Inc. Executive Dr. Brian Schwartz to the Company’s Board of Directors
8:18am
6-K
EX-10.1
2v2fmx 12
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-99.1
g3yvum x0y
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-4.1
0yqlih
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
yasxajho
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-4.2
1yzrg4y8pwvunwh
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
nei0 b92f3gsupn85n
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-4.1
t6ny3j
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
UPLOAD
yghzxg4mbeqs
3 Feb 20
Letter from SEC
12:00am
20-F/A
9o7da1ba
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
ecbiky y9q
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
5wkdscdo0y80i
31 Jan 20
Annual report (foreign) (amended)
4:31pm